2022 Worldwide revenue of $330.4 million – an increase of 20.4% year over year 2022 U.S. revenue of $277.2 million – an increase of 21.0% year over year 2022 International revenue of $53.2 million – an increase of 17.7% in 2022 February 21, 2023 04:00 PM Eastern Standard Time MASON, […]
Financial
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the fourth quarter and year ended December 31, 2022. Full year total revenues rose to a record $1.94 billion, as U.S. patients being treated with the company’s […]
Medtronic reports third quarter fiscal 2023 financial results
Delivers top and bottom line ahead of expectations, with strength in Cardiovascular and Neuroscience portfolios DUBLIN, Feb. 21, 2023 /PRNewswire/ — Medtronic plc (NYSE:MDT) today announced financial results for its third quarter of fiscal year 2023, which ended January 27, 2023. Key Highlights Revenue of $7.7 billion was flat as reported and increased 4.1% organic, […]
Esperion Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Company Update
– Landmark CLEAR Outcomes Trial Successfully Completed and Met the Major Adverse Cardiovascular Events (MACE-4) Primary Endpoint and Additional Key Secondary Endpoints; Additional Details in 11 Days at ACC.23/WCC – – Generated $15M in U.S. Net Sales in Q4 (+23% vs Q4 2021) and Full Year U.S. Net Sales of […]
Artivion Reports Fourth Quarter and Full Year 2022 Financial Results
Fourth Quarter and Recent Business Highlights: Achieved revenue of $79.4 million in the fourth quarter of 2022 versus $79.4 million in the fourth quarter of 2021, flat on a GAAP basis and an increase of 5% on a non-GAAP constant currency basis Achieved revenue of $313.8 million for the full year of 2022 versus $298.8 million for the […]
Shockwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results
SANTA CLARA, Calif., Feb. 16, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, today reported financial results for the three months and full year ended December 31, 2022. Recent Highlights Recognized revenue […]
Daxor Corporation Appoints Linda Cooper, Vice President Project Management
Oak Ridge, TN, Feb. 17, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the appointment of Linda Cooper as Vice President of Project Management. “Linda joins Daxor with over 30 years of experience in product development and commercialization in the medical device […]
Integer Holdings Corporation Reports Results for Fourth Quarter and Full Year 2022
~ Strong sales growth over last year of 19% in 4Q22 and 13% for the full year ~ ~ Expect 7% to 9% sales growth in 2023 with expanding margins ~ PLANO, Texas, Feb. 16, 2023 (GLOBE NEWSWIRE) — Integer Holdings Corporation (NYSE:ITGR), a leading medical device outsource manufacturer, today […]
egnite Brings Renowned Interventional Cardiologist, Rahul Sharma, onto Executive Team as Senior Medical Advisor
ALISO VIEJO, Calif.–(BUSINESS WIRE)–egnite, Inc., a leading digital-health company in the field of cardiovascular care, is proud to announce the appointment of Rahul P. Sharma, MD, MBBS, FRACP, as its new Senior Medical Advisor. A renowned interventional cardiologist, Sharma brings a wealth of knowledge and expertise to egnite’s executive team. With […]
HAYA Therapeutics Adds World-Leading Cardiologist and Dark Genome Pioneer to Advisory Boards
Ahmad Masri, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health & Science University, joins Clinical Advisory Board Cedric Feschotte, Professor, Department of Molecular Biology and Genetics at Cornell University, joins Scientific Advisory Board LAUSANNE, Switzerland & SAN DIEGO–(BUSINESS WIRE)–HAYA Therapeutics, SA, a company developing RNA-guided programmable precision medicines focused […]



